Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-04-16Clinical Trial Update: Effects of Cognitive Behavioral Therapy on Brain Serotonin Activity in People With Depression [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating the effects of cognitive behavioral therapy on brain serotonin activity in people with depression has …
-
FDA approval · 2020-04-15FDA Approved: NORTRIPTYLINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Nortriptyline Hydrochloride from Teva Pharmaceuticals USA, Inc., updating or expanding the d…
-
FDA approval · 2020-04-14FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for venlafaxine by BluePoint Laboratories, expanding its generic availability.
-
FDA approval · 2020-04-14FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride (generic Venlafaxine) by Aurobindo Pharma Limited.
-
FDA approval · 2020-04-10FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for venlafaxine from Alembic Pharmaceuticals.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Mechanisms of Antidepressant Non-Response in Late-Life Depression [NA]
Completed clinical trial investigating mechanisms of antidepressant non-response in late-life depression.
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Reducing the Burden of Depression Related Disability [NA]
A completed clinical trial exploring reducing disability related to depression; results posted in 2020.
-
FDA approval · 2020-04-08FDA Approved: FLUOXETINE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic fluoxetine product from Aurobindo Pharma Limited under an Original Application (ANDA 213286). Fluoxetine is an SSRI i…
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: Study Testing if Fast or Slow rTMS is Better for the Treatment of Posttraumatic Stress Disorder (PTSD) [NA]
Completed clinical trial comparing fast vs slow rTMS for PTSD with results posted in 2020.
-
FDA approval · 2020-04-07FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Original Application (AiPing Pharmaceutical, Inc.)
FDA approved a generic amitriptyline hydrochloride product from AiPing Pharmaceutical, Inc. under an original application.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Positive Valence System Enhancement Treatment for Anxiety and Depression: Clinical Efficacy and Neural Changes [NA]
A completed clinical trial examining a positive valence system enhancement treatment for anxiety and depression with reported clinical effic…
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: The Effect of Ketamine on Mechanises Underlying Suicidal Ideation and Drug-resistant Major Depression [Phase 3]
Phase 3 clinical trial investigating ketamine's effect on suicidal ideation and drug-resistant major depression.
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Stepped Telemental Health Care Intervention for Depression [NA]
Clinical trial completed evaluating a stepped telemental health intervention for depression; results posted in 2020.
-
FDA label_change · 2020-03-27FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SEROQUEL XR (quetiapine) from AstraZeneca, resulting in labeling updates for the drug.
-
CLINICAL_TRIALS research · 2020-03-24Clinical Trial Update: Study With Vortioxetine on Emotional Functioning in Patients With Depression [Phase 4]
A Phase 4 clinical trial evaluating vortioxetine on emotional functioning in patients with major depressive disorder has completed.
-
CLINICAL_TRIALS withdrawal · 2020-03-20Clinical Trial Update: Treatment for Cognitive Impairment in Depression [Phase 3]
A Phase 3 clinical trial for cognitive impairment in major depressive disorder was withdrawn.
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: Efficacy Study of Mirtazapine to Treat Interferon-related Depression During Antiviral Therapy for Hepatitis C [Phase 4]
Phase 4 trial updating efficacy of mirtazapine for interferon-related depression during antiviral therapy for hepatitis C; the study is term…
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Study to Learn About Relapse Prevention of Hypericumextract (a Drug Based on the Plant St. John Wort) in Outpatients Suffering From Moderate Depressive Episodes [Phase 3]
Phase 3 clinical trial evaluating Hypericum extract (St. John’s Wort) for relapse prevention in outpatients with moderate depressive episode…
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Comparing Effectiveness of Treating Depression With & Without Comorbidity to Improve Fetal Health
Completed clinical trial comparing treating depression with and without comorbidity to improve fetal health; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: Ketamine Infusion for Adolescent Depression and Anxiety [Phase 4]
Phase 4 trial update on ketamine infusion for adolescents with major depressive disorder and anxiety disorders has completed with results po…
-
FDA approval · 2020-03-12FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Advagen Pharma Ltd.)
FDA approved the original application for venlafaxine hydrochloride by Advagen Pharma Ltd., authorizing a generic version of this antidepres…
-
CLINICAL_TRIALS research · 2020-03-12Clinical Trial Update: Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women [NA]
A completed clinical trial evaluating collaborative care to reduce depression and increase cancer screening among low-income urban women.
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: Ketamine in the Treatment of Suicidal Depression [Phase 4]
Phase 4 trial update on ketamine for suicidal depression, documenting completed results.
-
CLINICAL_TRIALS trial_result · 2020-03-09Clinical Trial Update: A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder [Phase 3]
Phase 3 study of rapastinel as adjunctive therapy to prevent relapse in adults with major depressive disorder has completed with posted resu…
-
FDA approval · 2020-03-05FDA Approved: BUPROPION — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Bupropion by Zydus Pharmaceuticals USA Inc.